Pure Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
2,891
+2,062
| +249% | +$918K | 0.02% | 182 |
|
|
2025
Q1 | $402K | Buy |
829
+248
| +43% | +$120K | 0.01% | 270 |
|
|
2024
Q4 | $234K | Buy |
581
+21
| +4% | +$8.46K | 0.01% | 314 |
|
|
2024
Q3 | $261K | Buy |
560
+2
| +0.4% | +$931 | 0.01% | 290 |
|
|
2024
Q2 | $261K | Buy |
558
+25
| +5% | +$11.7K | 0.01% | 277 |
|
|
2024
Q1 | $223K | Buy |
+533
| New | +$223K | 0.01% | 288 |
|